Dose and volume de-escalation for HPV-associated oropharyngeal cancer: Long-term follow-up of the OPTIMA trial.

被引:0
|
作者
Rosenberg, Ari
Agrawal, Nishant
Pearson, Alexander T.
Seiwert, Tanguy Y.
Gooi, Zhen
Blair, Elizabeth A.
Cursio, John
Howard, Adam
Chin, Jeffrey
Foster, Corey Christian
Kochanny, Sara
Lingen, Mark W.
Haraf, Daniel J.
Vokes, Everett E.
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA
[3] Univ Chicago Med, Chicago, IL USA
[4] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[5] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
[6] Univ Chicago, Med & Biol Sci, Chicago, IL USA
[7] Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6575
引用
收藏
页数:2
相关论文
共 50 条
  • [1] OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
    Seiwert, T. Y.
    Foster, C. C.
    Blair, E. A.
    Karrison, T. G.
    Agrawal, N.
    Melotek, J. M.
    Portugal, L.
    Brisson, R. J.
    Dekker, A.
    Kochanny, S.
    Gooi, Z.
    Lingen, M. W.
    Villaflor, V. M.
    Ginat, D. T.
    Haraf, D. J.
    Vokes, E. E.
    ANNALS OF ONCOLOGY, 2019, 30 (02) : 297 - 302
  • [2] HPV-associated oropharyngeal cancer de-escalation strategies and trials: Past failures and future promise
    Zakeri, Kaveh
    Dunn, Lara
    Lee, Nancy
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (06) : 962 - 966
  • [3] Phase-II Trial of Therapy De-escalation in Patients with HPV-associated Oropharyngeal Cancer. Comment II
    Hermann, Robert Michael
    Christiansen, Hans
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (08) : 755 - 758
  • [4] Radiation Dose and Volume De-Escalation for High-Risk HPV Positive Oropharyngeal Cancer
    Iftekaruddin, Z.
    Arshad, M.
    Rosenberg, A. J.
    Hara, J.
    Pearson, A.
    Gooi, Z.
    Blair, E. A.
    Agrawal, N.
    Haraf, D. J.
    Vokes, E. E.
    Juloori, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S142 - S143
  • [5] Aggressive De-escalation in adjuvant Therapy for HPV-associated Oropharyngeal Cancer. Is Half of Everything enough?
    Hecht, Markus
    Semrau, Sabine
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (05) : 492 - 492
  • [6] Aggressive radiotherapy de-escalation for HPV-associated oropharyngeal carcinoma based on hypoxia dynamics
    Ruehle, Alexander
    Nicolay, Nils H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (06) : 570 - 573
  • [7] Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
    Chitsike, Lennox
    Duerksen-Hughes, Penelope J.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Dose and Volume De-Escalation for HPV-Positive Oropharyngeal Cancer is Associated with Favorable Post-Treatment Functional Outcomes
    Foster, C. C.
    Seiwert, T. Y.
    MacCracken, E.
    Blair, E. A.
    Agrawal, N.
    Melotek, J. M.
    Portugal, L.
    Brisson, R. J.
    Gooi, Z.
    Spiotto, M. T.
    Haraf, D. J.
    Vokes, E. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E419 - E419
  • [9] De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research
    Petar, Suton
    Marko, Skelin
    Ivica, Luksic
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (11) : 4599 - 4603
  • [10] De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research
    Suton Petar
    Skelin Marko
    Luksic Ivica
    European Archives of Oto-Rhino-Laryngology, 2021, 278 : 4599 - 4603